Cargando…
O09 - Early supplementation with Lactobacillus rhamnosus HN001 reduces eczema prevalence to 6 years: does it also reduce atopic sensitisation?
Autores principales: | Wickens, Kristin, Stanley, Thorsten, Mitchell, Edwin, Barthow, Christine, Fitzharris, Penny, Purdie, Gordon, Siebers, Robert, Black, Peter, Crane, Julian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4094203/ http://dx.doi.org/10.1186/2045-7022-4-S1-O9 |
Ejemplares similares
-
Early pregnancy probiotic supplementation with Lactobacillus rhamnosus HN001 may reduce the prevalence of gestational diabetes mellitus: a randomised controlled trial
por: Wickens, Kristin L., et al.
Publicado: (2017) -
Effect of Lactobacillus rhamnosus HN001 in Pregnancy on Postpartum Symptoms of Depression and Anxiety: A Randomised Double-blind Placebo-controlled Trial
por: Slykerman, R.F., et al.
Publicado: (2017) -
Lactobacillus rhamnosus HN001 Attenuates Allergy Development in a Pig Model
por: Thomas, Debra J., et al.
Publicado: (2011) -
Effect of Lactobacillus rhamnosus HN001 on carriage of Staphylococcus aureus: results of the impact of probiotics for reducing infections in veterans (IMPROVE) study
por: Eggers, Shoshannah, et al.
Publicado: (2018) -
The Probiotics in Pregnancy Study (PiP Study): rationale and design of a double-blind randomised controlled trial to improve maternal health during pregnancy and prevent infant eczema and allergy
por: Barthow, Christine, et al.
Publicado: (2016)